Paine Webber just listed Diacrin as a long term perform. I've done a bit of research and feel this isn't a bad play. They've got 22M in cash with a 300K burn rate. They are working on an Alzheimer's and a Parkinson's drug which sounds good. If anyone has any thoughts let me know what you think.Chris H
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst R